Dina Visca

5.5k total citations · 1 hit paper
89 papers, 2.1k citations indexed

About

Dina Visca is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Infectious Diseases. According to data from OpenAlex, Dina Visca has authored 89 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Pulmonary and Respiratory Medicine, 33 papers in Physiology and 24 papers in Infectious Diseases. Recurrent topics in Dina Visca's work include Chronic Obstructive Pulmonary Disease (COPD) Research (35 papers), Asthma and respiratory diseases (26 papers) and Tuberculosis Research and Epidemiology (17 papers). Dina Visca is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (35 papers), Asthma and respiratory diseases (26 papers) and Tuberculosis Research and Epidemiology (17 papers). Dina Visca collaborates with scholars based in Italy, United Kingdom and Brazil. Dina Visca's co-authors include Antonio Spanevello, Giovanni Battista Migliori, Rosella Centis, Lia D’Ambrosio, Giovanni Sotgiu, Elisabetta Zampogna, Fabio Angeli, Paolo Verdecchia, Simon Tiberi and Patrizia Pignatti and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Respiratory Journal and Physical Therapy.

In The Last Decade

Dina Visca

79 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects

2021 194 citations Dina Visca, Rosella Centis et al. Pulmonology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dina Visca Italy	26	825	784	400	329	267	89	2.1k
Zongan Liang China	24	506 0.6×	933 1.2×	453 1.1×	182 0.6×	290 1.1×	123	2.1k
Lara Zafrani France	27	901 1.1×	478 0.6×	650 1.6×	102 0.3×	446 1.7×	109	2.8k
Coenraad F.N. Koegelenberg South Africa	28	695 0.8×	1.4k 1.8×	564 1.4×	193 0.6×	95 0.4×	159	2.5k
Jianchu Zhang China	21	750 0.9×	360 0.5×	182 0.5×	174 0.5×	276 1.0×	69	1.7k
Randeep Guleria India	22	246 0.3×	765 1.0×	398 1.0×	301 0.9×	59 0.2×	113	1.9k
Paolo Solidoro Italy	26	208 0.3×	846 1.1×	567 1.4×	273 0.8×	103 0.4×	159	2.0k
Jiaofeng Huang China	19	889 1.1×	142 0.2×	922 2.3×	224 0.7×	430 1.6×	47	2.1k
Miklós Lipcsey Sweden	22	534 0.6×	325 0.4×	641 1.6×	108 0.3×	430 1.6×	193	2.2k
Rahul Kumar Singapore	18	893 1.1×	169 0.2×	961 2.4×	143 0.4×	430 1.6×	63	2.2k
Su Hwan Lee South Korea	17	353 0.4×	349 0.4×	303 0.8×	176 0.5×	119 0.4×	79	1.3k

Countries citing papers authored by Dina Visca

Since Specialization

Citations

This map shows the geographic impact of Dina Visca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dina Visca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dina Visca more than expected).

Fields of papers citing papers by Dina Visca

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dina Visca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dina Visca. The network helps show where Dina Visca may publish in the future.

Co-authorship network of co-authors of Dina Visca

This figure shows the co-authorship network connecting the top 25 collaborators of Dina Visca. A scholar is included among the top collaborators of Dina Visca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dina Visca. Dina Visca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ambrosino, Pasquale, Antonino Di Stefano, Isabella Gnemmi, et al.. (2025). Cytokine and Metabolomic Signatures of Mepolizumab Response Across Upper and Lower Airway Compartments in Severe Eosinophilic Asthma: An Exploratory Analysis. Pharmaceuticals. 18(11). 1704–1704. 1 indexed citations

Bagnasco, Diego, Luisa Brussino, Stefania Nicola, et al.. (2025). Dupilumab Effectiveness in Patients with Severe Allergic Asthma Non-Responsive to Omalizumab. Journal of Personalized Medicine. 15(2). 43–43.

Pignatti, Patrizia, Dina Visca, Martina Zappa, et al.. (2024). Monitoring COPD patients: systemic and bronchial eosinophilic inflammation in a 2-year follow-up. BMC Pulmonary Medicine. 24(1). 247–247. 3 indexed citations

Silva, Denise Rossato, Dina Visca, Sidney Bombarda, et al.. (2023). Brazilian Thoracic Association recommendations for the management of post-tuberculosis lung disease. Jornal Brasileiro de Pneumologia. 49(6). e20230269–e20230269. 10 indexed citations

Saderi, Laura, Andrea Maurizio Cabibbe, Mariangela Valentina Puci, et al.. (2023). A systematic review of the costs of diagnosis for multidrug-resistant/extensively drug-resistant TB in different settings. The International Journal of Tuberculosis and Lung Disease. 27(5). 348–356. 3 indexed citations

Gallo, Stefania, Paolo Castelnuovo, Veronica Seccia, et al.. (2022). Mepolizumab Improves Outcomes of Chronic Rhinosinusitis with Nasal Polyps in Severe Asthmatic Patients: A Multicentric Real-Life Study. Journal of Personalized Medicine. 12(8). 1304–1304. 30 indexed citations

Angeli, Fabio, Paolo Verdecchia, Claudio Bruschi, et al.. (2022). Renin Angiotensin System Blockers and Risk of Mortality in Hypertensive Patients Hospitalized for COVID-19: An Italian Registry. Journal of Cardiovascular Development and Disease. 9(1). 15–15. 15 indexed citations

Zampogna, Elisabetta, Giovanni Battista Migliori, Rosella Centis, et al.. (2021). Functional impairment during post-acute COVID-19 phase: Preliminary finding in 56 patients. Pulmonology. 27(5). 452–455. 25 indexed citations

Angeli, Fabio, Jacopo Marazzato, Paolo Verdecchia, et al.. (2021). Joint effect of heart failure and coronary artery disease on the risk of death during hospitalization for COVID-19. European Journal of Internal Medicine. 89. 81–86. 17 indexed citations

10.

Zampogna, Elisabetta, Giorgio Bertolotti, Nicolino Ambrosino, et al.. (2021). The Maugeri daily activity profile: a tool to assess physical activity in patients with chronic obstructive pulmonary disease. Monaldi Archives for Chest Disease. 91(4).

11.

Migliori, Giovanni Battista, Dina Visca, Martin van den Boom, et al.. (2021). Tuberculosis, COVID-19 and hospital admission: Consensus on pros and cons based on a review of the evidence. Pulmonology. 27(3). 248–256. 27 indexed citations

12.

Zampogna, Elisabetta, Mara Paneroni, Stefano Belli, et al.. (2021). Pulmonary Rehabilitation in Patients Recovering from COVID-19. Respiration. 100(5). 416–422. 83 indexed citations

13.

Irfan, Muhammad, Kauser Jabeen, Nousheen Iqbal, et al.. (2020). Post tuberculosis treatment infectious complications. International Journal of Infectious Diseases. 92. S41–S45. 34 indexed citations

14.

Akkerman, Onno W., Lies ter Beek, Rosella Centis, et al.. (2020). Rehabilitation, optimized nutritional care, and boosting host internal milieu to improve long-term treatment outcomes in tuberculosis patients. International Journal of Infectious Diseases. 92. S10–S14. 21 indexed citations

15.

Stock, Carmel, Rachel K. Hoyles, Cécile Daccord, et al.. (2020). Serum markers of pulmonary epithelial damage in systemic sclerosis‐associated interstitial lung disease and disease progression. Respirology. 26(5). 461–468. 35 indexed citations

16.

Tiberi, Simon, Marcela Muñóz-Torrico, Maria Krutikov, et al.. (2019). Managing severe tuberculosis and its sequelae: from intensive care to surgery and rehabilitation. Jornal Brasileiro de Pneumologia. 45(2). e20180324–e20180324. 26 indexed citations

17.

Pontali, Emanuele, Giovanni Sotgiu, Simon Tiberi, et al.. (2018). Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review. European Respiratory Journal. 52(1). 1800934–1800934. 39 indexed citations

18.

Matteelli, Alberto, Adrián Rendón, Simon Tiberi, et al.. (2018). Tuberculosis elimination: where are we now?. European Respiratory Review. 27(148). 180035–180035. 72 indexed citations

19.

Silva, Denise Rossato, Margareth Pretti Dalcolmo, Simon Tiberi, et al.. (2018). New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis. Jornal Brasileiro de Pneumologia. 44(2). 153–160. 43 indexed citations

20.

Maas, Jolanda, Robert Verheij, Peter Spreeuwenberg, et al.. (2005). Track 4: Workshop: Linking health promotion and health care. European Journal of Public Health. 15(suppl_1). 14–16. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact